Peritoneal carcinomatosis treated with cytoreductive surgery and intraperitoneal chemotherapy
Conclusion The combined treatment for peritoneal carcinomatosis may be performed safely with acceptable morbidity and mortality in a specialized unit setting. Although over half of patients underwent normothermic intraperitoneal chemotherapy, our results were comparable to results from others centers.
Source: Journal of Coloproctology - Category: Gastroenterology Source Type: research
More News: Asbestosis | Blood Transusion | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Colorectal Cancer | Mesothelioma | Peritoneal Cancer | Women